Galectin Therapeutics Chairman Discusses Details of Fast

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Galectin Therapeutics Chairman Discusses Details of Fast Track Designation Today at 11 A.M.

ORLANDO, Fla., Aug. 16, 2013 (GLOBE NEWSWIRE) -- RedChip Companies, Inc. ("RedChip"), an international small-cap research, investor relations, and financial media company, today announced that Jim Czirr, executive chairman of Galectin Therapeutics (Nasdaq: GALT ), a leading developer of therapeutics that target galectin proteins, will appear in an interview today on RedChip's Internet TV platform at 11:00 a.m. Eastern time. The interview will stream at http://www.redchip.com .

The interview will be hosted by Dave Gentry, president of RedChip and host of "The RedChip Money Report: Small Stocks Big Money," which airs weekly (Thursdays 10 p.m. PT/Fridays 1 a.m. ET) in 65 million homes on the Fox Business Network. 

During the interview, Mr. Czirr will discuss the implications and details of the FDA's Fast Track designation of their clinical trial for the treatment of fatty liver disease with advanced fibrosis. Mr. Czirr will provide key insights about the nature of the trial and the potential long-term benefits for those with fatty liver disease with advanced fibrosis. 

Galectin Therapeutics was first featured on "The RedChip Money Report" on November 3, 2012. Shares of Galectin Therapeutics are up 254% since Mr. Czirr's first appearance on "The RedChip Money Report" TV show.

About RedChip Companies, Inc.

RedChip Companies, an Inc. 5000 company, is an international small-cap research, investor relations, and media company headquartered in Orlando, Florida; with affiliate offices in San Francisco, Pittsburgh, San Antonio, and Seoul. RedChip delivers concrete, measurable results for its clients through its extensive global network of small-cap institutional and retail investors. RedChip has developed the most comprehensive platform of products and services for small-cap companies, including: RedChip Research™, Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences, Virtual Conferences, "The RedChip Money Report: Small Stocks Big Money"™ television show, Shareholder Intelligence, Strategic Marketing, Crisis Management, Social Media and Blogging Services, and Webcasts. To learn more about RedChip's products and services, please visit: http://www.redchip.com/visibility/productsandservices.asp .

"Discovering Tomorrow's Blue Chips Today"™

Jon Cunningham RedChip Companies, Inc. Tel: 1-800-RED-CHIP (733-2447), ext. 107 Email:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Navigating Cash Investments in a Shifting Yield Environment

Updated Category News Views 86

Understanding Recent Trends in the Yield Curve Recent conversations among analysts reveal a careful balance in cash and investment strategies, especially regarding potential interest rate cuts. While some believe these cuts could lead to a shift away from cash-like instruments, the situation is more nuanced. Certain segments of shorter-dated government bonds may take a...

Continue Reading
Air Canada Resumes Flights After Government Arbitration Ruling

Updated Category News Views 229

Air Canada Resumes Operations After Government Decision Air Canada has announced plans to resume flights after receiving a directive from the Canadian Industrial Relations Board (CIRB). This decision follows a government referral of existing contract negotiations between the airline and the Canadian Union of Public Employees (CUPE) to binding arbitration. Details of the...

Continue Reading
Prenosis Secures $20M Funding to Elevate Patient Outcomes

Updated Category News Views 206

Prenosis Secures $20 Million Funding for Diagnostic Innovations In a significant stride towards advancing patient care, Prenosis, a leading biology-based technology firm, announced its successful completion of a $20 million Series A financing round alongside securing a $20 million contract from the Biomedical Advanced Research and Development Authority (BARDA). This dual...

Continue Reading
Cherokee Federal Strengthens Security Services with Key Hire

Updated Category News Views 156

Cherokee Federal Expands Its Team for Enhanced Security Solutions Cherokee Federal, part of Cherokee Nation Businesses, is making significant strides in the federal contracting arena, particularly within the homeland security sector. The growing demand for effective security solutions prompted the company to enhance its capabilities. Recently, Cherokee Federal announced...

Continue Reading
China's Economic Strategies Foster Stability and Growth

Updated Category News Views 178

China's Economic Strategies Foster Stability and Growth In a recent report, Chinese officials have conveyed their strong confidence in the country's financial market, emphasizing the need for sustained and stable development. This determination reflects the country's proactive measures to adapt to an ever-evolving economic landscape. Government Initiatives to Boost Market...

Continue Reading